Empirical Wealth Management’s GSK GSK Stock Holding History

Empirical Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Sell	4,324 -135	-3%	-$7.14K	﹤0.01%	978
2026 Q1	$246K	Buy	+4,459	New	+$242K	﹤0.01%	872
2021 Q3	–	Sell	-6,227	Closed	-$310K	–	466
2021 Q2	$310K	Buy	+6,227	New	+$299K	0.02%	364

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Empirical Wealth Management's GSK Position: Q2 2026 in Review

Empirical Wealth Management reduced its GSK (GSK) stake by 3% in Q2 2026, selling an estimated $7.14K and leaving 4,324 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Empirical Wealth Management first reported a position in GSK in Q2 2021 and has held it in 3 quarters since. The position peaked at $310K in Q2 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Empirical Wealth Management held 4,324 shares of GSK worth $227K as of Q2 2026.
Empirical Wealth Management sold 135 GSK shares in Q2 2026, an estimated $7.14K.
GSK made up ﹤0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #978 holding.
Empirical Wealth Management first reported a position in GSK in Q2 2021 and has held it in 3 quarters since.
Empirical Wealth Management's GSK position peaked at $310K in Q2 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.